Porcellati, Francesca

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 818

Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM.

Fanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 398

Long-Term Intensive Therapy of IDDM Patients With Clinically Overt Autonomic Neuropathy: Effects on Hypoglycemia Awareness and Counterregulation

Fanelli, C., Pampanelli, S., Lalli, C., Sindaco, P. D., Ciofetta, M., Lepore, M., Porcellati, F., Bottini, P., Di Vincenzo, A., Brunetti, P., et al. (1997) · Diabetes

Diabetes Management and ResearchCardiovascular Syncope and Autonomic Disorders

Cited by 63

Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes

Porcellati, F., Lucidi, P., Cioli, P., Candeloro, P., Marinelli Andreoli, A., Marzotti, S., Ambrogi, M., Bolli, G. B., & Fanelli, C. G. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 52

Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology

Lucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Current Diabetes Reports

Diabetes Management and ResearchDiabetes Management and Education

Cited by 38

Comparative effectiveness of switching from first-generation basal insulin to glargine 300 u/ml or degludec 100 u/ml in type 1 diabetes: The RESTORE-1 study

the RESTORE-1 Study Group, Laviola, L., Porcellati, F., Bruttomesso, D., Larosa, M., Rossi, M. C., & Nicolucci, A. (2021) · Diabetes Therapy

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 16

Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review

Barana, L., De Fano, M., Cavallo, M., Manco, M., Prete, D., Fanelli, C. G., Porcellati, F., & Pippi, R. (2025) · Nutrients

Pharmacology and Obesity TreatmentNutrition and Health in Aging

Cited by 13

The Sweet Side of Constipation: Colonic Motor Dysfunction in Diabetes Mellitus

De Fano, M., Baluganti, S., Manco, M., Porcellati, F., Fanelli, C. G., & Bassotti, G. (2025) · Nutrients

Gastrointestinal motility and disordersPelvic floor disorders treatments

Cited by 4

A New Role for Glucagon: From Secondary Hormone to Key Player

De Fano, M., Malara, M., Rucco, S., Manco, M., Fanelli, C. G., Bolli, G. B., & Porcellati, F. (2025) · Nutrition, Metabolism and Cardiovascular Diseases

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 1